PMDA — authorised 20 September 2019
- Marketing authorisation holder: Astellas Pharma Inc.
- Status: approved
🇯🇵 Evrenzo in Japan
PMDA authorised Evrenzo on 20 September 2019
Marketing authorisations
PMDA
- Application: Evrenzo
- Local brand name: Evrenzo
- Status: approved
Evrenzo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Japan
Frequently asked questions
Is Evrenzo approved in Japan?
Yes. PMDA authorised it on 20 September 2019; PMDA has authorised it.
Who is the marketing authorisation holder for Evrenzo in Japan?
Astellas Pharma Inc. holds the Japanese marketing authorisation.